Olympus Aspartate Aminotransferase Reagent
by Olympus Corp. 510(k) 2 variants
Active
510(k) K925155
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK925155 | Date26 Jan 1993 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- CIT
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.1100
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 25 Sep 2026
The Olympus Aspartate Aminotransferase Reagent is a clinical chemistry reagent used for the measurement of aspartate aminotransferase (AST/SGOT) through NADH oxidation/NAD reduction method. It is classified under product code CIT for clinical chemistry applications.
This reagent is supplied by Olympus Corp. and is intended for laboratory use. It is a Class II device cleared by the FDA under 510(k) K925155 and K922885, with clearance dates of January 26, 1993, and July 28, 1992, respectively. The device is not specified as single-use or reusable, and no information regarding sterility, MRI safety, or storage conditions is provided in the data.
Other devices from Olympus Corp.
Questions
AI-generated answers, 25 Sep 2026
What is the Olympus Aspartate Aminotransferase Reagent used for?
The Olympus Aspartate Aminotransferase Reagent is used for the measurement of aspartate aminotransferase (AST/SGOT) through the NADH oxidation/NAD reduction method in clinical chemistry applications.
How is the Olympus Aspartate Aminotransferase Reagent supplied and intended for use?
The reagent is supplied by Olympus Corp. and is intended for laboratory use in clinical chemistry testing to measure AST/SGOT levels.
What regulatory pathway was used for the Olympus Aspartate Aminotransferase Reagent?
The device was cleared by the FDA through the 510(k) pathway, with substantial equivalence demonstrated under K925155 (cleared January 26, 1993) and K922885 (cleared July 28, 1992).